We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Integrated Database Helps Detect Biomarkers to Neurological Diseases

By LabMedica International staff writers
Posted on 20 May 2009
A searchable, integrated database of human genes provides concise genomic, proteomic, transcriptomic, genetic, and functional information on all known and predicted human genes. More...
It will be used to identify and characterize protein biomarkers for serious neurological diseases.

Information featured in the database, which is called GeneCards, includes orthologies, disease relationships, mutations and single nucleotide polymorphisms (SNPs), gene expression, gene function, pathways, protein-protein interactions, related drugs and compounds, and direct links to research reagents and tools such as antibodies, recombinant proteins, clones, expression assays and RNAi reagents.

GeneCards was developed by a bioinformatics team at the Weizmann Institute of Science (Rehovot, Israel) directed by Marilyn Safran and Prof. Doron Lancet of the department of molecular genetics, and head of the Crown Human Genome Center.

Xennex (Cambridge MA, USA) has provided Satoris (Redwood City, CA, USA) with access to GeneCards and associated tools. Satoris is utilizing GeneCards and the related technology for investigations related to its identification and characterization of protein biomarkers associated with neurological disease such as Alzheimer's, Parkinson's, multiple sclerosis, and diabetic neuropathy, to create new diagnostic tools for earlier, better healthcare decisions.

The newly released GeneCards Version 3.0 features a significantly upgraded infrastructure, including a comprehensive relational biological database, and a sophisticated, and speedier search engine. It provides capabilities for effective and well-targeted queries, a user-friendly display, and clear data navigation. Also released, a preliminary version of GeneDecks Version 3, which makes use of the new GeneCards relational database for complex analyses on sets of genes.

Dr. David Warshawsky, president & CEO of Xennex, stated: "We are very pleased that we can offer Satoris our most advanced tools and the latest GeneCards developments to assist in their work. Satoris' work is of great potential for improved diagnosis and treatment of devastating conditions."

Related Links:

GeneCards
Weizmann Institute of Science
Xennex
Satoris



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.